Hadassah Medical Center and Neurogenesis Announce Groundbreaking Results from a Phase 2 Study in Progressive Multiple Sclerosis treated with NG-01 Autologous Cells Therapy ...Middle East

PR Newswire - News
JERUSALEM, Dec. 8, 2020 /PRNewswire/ -- NeuroGenesis, a clinical-stage biopharmaceutical company advancing innovative cell therapies to combat myelin-related neurodegenerative diseases, and Hadassah Medical Center announced today highly positive results from a placebo-controlled Phase 2...

Hence then, the article about hadassah medical center and neurogenesis announce groundbreaking results from a phase 2 study in progressive multiple sclerosis treated with ng 01 autologous cells therapy was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Hadassah Medical Center and Neurogenesis Announce Groundbreaking Results from a Phase 2 Study in Progressive Multiple Sclerosis treated with NG-01 Autologous Cells Therapy )

Apple Storegoogle play

Last updated :

Also on site :